Format

Send to

Choose Destination
J Hepatol. 2019 Sep 5. pii: S0168-8278(19)30425-8. doi: 10.1016/j.jhep.2019.07.016. [Epub ahead of print]

Canadian liver transplant allocation for hepatocellular carcinoma.

Author information

1
Division of Gastroenterology, Department of Medicine, and Multi Organ Transplant Unit, London Health Sciences Centre, Western University, London, Ontario, Canada.
2
Division of Gastroenterology, Faculty of Medicine, The University of British Columbia, Vancouver, BC, Canada.
3
Department of Surgery, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.
4
Department of Medicine, Multi-Organ Transplant Program, Toronto General Hospital, Toronto, Canada.
5
Department of Medicine, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.
6
Division of Gastroenterology and Hepatology, McGill University Health Centre, Royal Victoria Hospital, Montréal, Quebec, Canada.
7
Division of Digestive Care & Endoscopy, Dalhousie University and Atlantic Multi-Organ Transplantation Program, QEII Health Sciences Centre, Halifax, Nova Scotia, Canada.
8
Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
9
Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada. Electronic address: secongly@ucalgary.ca.

KEYWORDS:

Canada; Carcinoma; Health policy; Hepatocellular; Liver neoplasms; Liver transplantation; Tumour burden

PMID:
31495534
DOI:
10.1016/j.jhep.2019.07.016

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center